Sino Biopharmaceutical Limited (HKG:1177)
4.905
+0.020 (0.41%)
Nov 4, 2026, 11:59 AM HKT
Sino Biopharmaceutical Employees
Sino Biopharmaceutical had 22,838 employees as of June 30, 2026. That makes Sino Biopharmaceutical the 1,613th largest employer in the world and 148th in Hong Kong.
Employees
22,838
Change (1Y)
n/a
Growth (1Y)
n/a
Revenue / Employee
1.70M HKD
Profits / Employee
120.78K HKD
Market Cap
87.36B
Employees Chart
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Jun 30, 2026 | 22,838 | - | - |
| Dec 31, 2025 | 21,435 | -2,944 | -12.08% |
| Dec 31, 2024 | 24,379 | -1,427 | -5.53% |
| Dec 31, 2023 | 25,806 | -466 | -1.77% |
| Dec 31, 2022 | 26,272 | 693 | 2.71% |
| Dec 31, 2021 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2021 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Sep 30, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Sep 30, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| WuXi Biologics | 14,705 |
| BeOne Medicines AG | 12,000 |
| Innovent Biologics | 8,754 |
| Genscript Biotech | 6,135 |
| 3SBio | 6,068 |
| Akeso | 4,082 |
| Shanghai Henlius Biotech | 4,082 |
| RemeGen | 3,145 |
Sino Biopharmaceutical News
- 2 days ago - Sino Biopharmaceutical Limited - Depositary Receipt Consensus Price Target Decreased by 15.14% to $21.83 - Nasdaq
- 11 days ago - Sino Biopharmaceutical Limited - Depositary Receipt Consensus Price Target Increased by 54.99% to $25.72 - Nasdaq
- 15 days ago - Transcenta Appoints Former Sino Biopharmaceutical CFO Jennie Ma - Nasdaq
- 2 months ago - Sino Biopharmaceutical Limited Unveils New Global Brand, SBP Group, to Accelerate International Expansion - PRNewsWire
- 2 months ago - Sino Biopharmaceutical Earnings release: H1 2026 - Filings
- 2 months ago - Sino Biopharmaceutical Quarterly report: H1 2026 - Filings
- 3 months ago - Sino Biopharmaceutical, GSK expand alliance with China rights to respiratory drugs - Reuters
- 3 months ago - AstraZeneca, Sino Biopharm Sign Up to $1.9 Billion Respiratory Drug Licensing Deal - WSJ